Abstract Effective therapeutic measures against the development of brain edema, a life-threatening complication of cerebral ischemia, are necessary to improve the functional outcome for the patient. Here, we identified a beneficial role of purinergic receptor P2X7 activation in acute ischemic stroke. Involvement of P2X7 in the development of neurological deficits, infarct size, brain edema, and glial responses after ischemic cerebral infarction has been analyzed. Neurologic evaluation, magnetic resonance imaging, and immunofluorescence assays were used to characterize the receptor's effect on the disease progress during 72 h after transient middle cerebral artery occlusion (tMCAO). Sham-operated animals were included in all experiments for control purposes. We found P2X7-deficient mice to develop a more prominent brain edema with a trend towards more severe neurological deficits 24 h after tMCAO. Infarct sizes, T2 times, and apparent diffusion coefficients did not differ significantly between wild-type and P2X7 −/− animals.
Introduction
Ischemic stroke is one of the most important vascular diseases, which causes loss of nervous tissue and may lead to severe disability or even death. A major complication is the development of brain edema, which Electronic supplementary material The online version of this article (doi:10.1007/s11302-016-9511-x) contains supplementary material, which is available to authorized users. exerts pressure on neighboring tissues and further aggravates the disease. Despite the clinical importance of the disease, knowledge gaps concerning the pathophysiology of cerebral ischemia continue to complicate the search for an effective therapy.
The purinergic receptor P2X7, an ATP-gated cation channel belonging to the purinergic P2 receptor family, has been shown to affect pathophysiological events following brain ischemia. P2X7 is a low-affinity ATP receptor mainly expressed on immune and glial cells. Regarding the central nervous system, P2X7 is known to be present on microglia, astrocytes, oligodendrocytes, and some neuronal populations [1] . Inflammation and tissue trauma may entail high extracellular ATP concentrations [2] and trigger the activation of P2X7 [3] . Subsequent Ca 2+ entry may cause neuronal and oligodendrocyte cell death [4, 5] , but activation of P2X7 has also been shown to induce microglia proliferation [6] . Consistently, the receptor is involved in pathophysiological events following ischemic brain damage, but studies to clarify its exact role yielded inconsistent results.
On the one hand, a detrimental pro-inflammatory role is attributed to P2X7 in experimental brain injury, which was reversible by antagonists or diminished by gene knockout [7, 8] . These results are in agreement with the fact that the maturation and release of IL-1β as well as the generation of reactive oxygen species, both pathologic stimuli in experimental and human stroke [9, 10] , are triggered upon the activation of the receptor [11] .
On the other hand, results obtained by pharmacological modulation of P2X7 point towards a beneficial function of the receptor, presumably conveyed by activating neuroprotective responses in glial cells [12] . In fact, P2X7-bearing microglia and astrocytes may contribute to the reduction of neuronal cell death [13, 14] . A primary in vivo study did not argue for an influence of P2X7 on the infarct volume 24 h after ischemia [15] ; however, no further infarct parameters or time points were investigated.
In this context, we evaluated the contribution of P2X7 to the outcome after middle cerebral artery occlusion (MCAO), an established model of ischemic stroke, in mice after surgery for the subsequent 72 h. We applied clinical, nuclear magnetic resonance (NMR) imaging, and immunofluorescence methods to obtain data regarding neurological deficits, infarct size, brain edema, and glial cell activation. Our results are compatible with a protective role of P2X7 during initial phases after the onset of ischemia. At later time points, microglia activation was supported by P2X7, but no significant differences were observed with respect to the clinical outcome.
Material and methods

Animals
Mouse breeding and experiments were performed in the animal facility of the Faculty of Medicine, University of Leipzig according to the ARRIVE guidelines as well as the European (Council Directive 2010/63/EU) and German guidelines for the welfare of experimental animals and were approved by the local authorities (Landesdirektion Leipzig; ID: TVV 64/ 13). All possible efforts were made to replace, reduce, and refine experiments including laboratory animals. Male mice (25-35 g ) with P2X7
−/− or wild-type (WT) genotype of C57BL/6 J background originally purchased from the Jackson Laboratory (Bar Harbor, ME, USA) were used [16] . Mice were housed under standard conditions with free access to food and water and a 12-h light-dark cycle with lights on from 7:00 a.m. From first NMR session on, animals were housed individually.
Surgical procedures
Anesthesia was induced with 2.5 % of isoflurane (Baxter, Unterschleissheim, Germany) in oxygen and maintained with 1.5 % of the anesthetic. Analgesia was assured by subcutaneous injection of 200 mg/kg metamizol (WDT, Garbsen, Germany), a non-opioid analgesic with only weak antiinflammatory effects. Metamizol was administered before surgery and every 6 hours afterwards. MCAO was essentially achieved as described before with minor modifications [17] . Briefly, after a midline neck incision, the left common carotid artery (CCA) and its bifurcation into the external (ECA) and internal carotid artery (ICA) were exposed and carefully separated from the adjacent vagus nerve. The CCA as well as the ECA were ligated (Suprama Silk 7-0, Feuerstein, Berlin, Germany) while blood flow through the ICA was impeded by a microvascular clip. A polysiloxane-coated filament (Suprama Nylon 8-0, Feuerstein) coated with Xantopren M mucosa (Heraeus Kulzer GmbH, Hanau, Germany) was then inserted through a small opening cut into the CCA distal to the ligature. Upon removal of the microvascular clip, the filament was advanced approximately 11 mm along the ICA into the circle of Willis, where it blocked the origin of the middle cerebral artery (MCA). The filament was immediately removed in sham-operated animals or after 60 min in mice undergoing transient MCAO (tMCAO). It remained in place in animals belonging to the permanent MCAO (pMCAO) group. The ICA was then ligated (Suprama Silk 5-0, Feuerstein) and the neck incision closed.
Neurological score
Neurological deficits were evaluated daily, and a neurological score based on a scale described before [18] was assigned to each animal. Initially, mice were suspended by their tail above the surface of a table. Animals able to extend both forelimbs towards the surface were scored 0. If the right forelimb remained flexed and subsequent tests did not reveal further neurological deficits, the score was set to 1. Mice given a score of 2 showed decreased loading of the right forelimb when moving without the support of the hind limbs as by elevating them by the tail. If fixation of the animal by the tail caused them to move in circles, they were scored 3. Circling behavior when allowed to move freely resulted in a score of 4. Severely reduced general condition and inability to move resulted in a score of 5 and immediate euthanasia.
Magnetic resonance imaging protocol and image analysis
One and 3 days after MCAO, mice were anesthetized with 75 mg/kg ketamine (WDT) and 6 mg/kg xylazine (Bayer Health Care, Leverkusen, Germany Image analysis was performed in a randomized, blinded fashion using custom MATLAB scripts. First, RARE images were used to create a mask for each of the nine slices including only the brain to speed up analysis. These masks were then downsampled for further analysis of T2 and DWI image trains to the desired resolution (256 × 128 for T2 and 128 × 64 for DWI), including only pixels in the low resolution mask if at least half of the corresponding pixels formed part of the highresolution mask from the RARE. T2 and ADC maps were calculated using a mono-exponential fitting function. However, as the images show a significant noise floor due to limited scanning time, the fitting functions for T2 and ADC were corrected for an offset term (determined as mean value of an area including pure noise). T2 maps were then adjusted in brightness and contrast to define a region of interest (ROI) with altered T2 values. All ROIs were then summed up to a volume of interest (VOI) representing the size of the infarct. A corresponding VOI on the contralateral site was created using mirroring (slightly adjusted to not include physiologically hyperintense neuroanatomic regions) (Online Resource 1C). For these two VOIs (ipsi-and contralateral), mean values for T2 times and ADC were calculated. Mice with no observable altered region in the whole brain were analyzed in the same manner by drawing VOIs similar to those in animals with cerebral infarction.
Second, the position of the midline was determined using neuroanatomic landmarks such as the fissura longitudinalis, lateral, and third ventricles in three consecutive slices (Online Resource 1B). The percentage of the infarcted hemisphere as a proportion of the total brain volume in the middle slice was used to describe oedematous brain swelling. Eventually, swelling of the infarcted hemisphere was put in relation to the size of the ischemic lesion.
Immunofluorescence staining
Animals were deeply anesthetized and transcardially perfused (2 % paraformaldehyde in sodium acetate buffer containing 10 IU/ml heparin, pH 6.5, followed by 2 % paraformaldehyde in sodium borate buffer containing 0.15 % glutaraldehyde, pH 8.5). Brains were immediately removed and stored in the latter solution. In preparation for immunofluorescence staining, coronal sections (50 μm) were cut using a vibratome (Leica, Typ VT 1200S, Nussloch, Germany) and collected as free-floating slices. Unspecific protein binding was prevented by blocking for 30 min with 5 % fetal calf serum (Sigma-Aldrich, St. Louis, MO, USA) dissolved in 0.05 M Tris-buffered saline (TBS;pH 7.6; Sigma-Aldrich) and 10 % Triton X-100 (Sigma-Aldrich). Slices were then incubated with primary antibodies rabbit anti-ionized calcium binding adaptor molecule 1 (Iba1; 1:1000; Wako Chemicals GmbH, Neuss, Germany), mouse anti-glial fibrillary acidic protein (GFAP; 1:1000; Dako Cytomation, Glostrup, Denmark), and rabbit anti-laminin (1:50; Dako) for 48 h at 4°C. Following subsequent washing steps with TBS, slices were exposed to secondary antibodies Cy3-conjugated donkey anti-rabbit IgG (1:800; Jackson ImmunoResearch, West Grove, PA, USA) or Cy5-conjugated donkey anti-mouse IgG (1:800; Jackson ImmunoResearch) for 2 h at room temperature. Slices were then mounted on slide glasses, dehydrated in ethanol, cleared in n-butylacetate, embedded in Entellan (Merck, Darmstadt, Germany), and covered.
Confocal microscopy and quantification
Immunofluorescence was examined using a confocal laser scanning microscope (LSM 510 Meta, Zeiss, Oberkochen, Germany) equipped with two helium/neon lasers emitting at 543 and 633 nm, respectively. Cy5-labeled signals were color coded in green. Images taken with a Plan-Neofluar 10x/0.3 objective allowed visualization of infarct core, penumbra, and surrounding tissues and served as a template to define regions of interest (ROIs). While the infarcted tissue was characterized by loss of cellular integrity and only permitted measurements of unspecific immunofluorescence, the infarct border itself was strongly demarcated by activated microglia, and intense GFAP immunofluorescence could be seen somewhat further from the infarct core. In order to establish spatial profiles of glial responses, we thus positioned ROIs so that they encompassed the infarct border and the surrounding tissue. Immunofluorescence intensity along three such ROIs per animal was measured, corrected for the respective background signals, and normalized to unaffected brain regions to compensate for uneven staining in different slices. Similarly, three ROIs were defined to count microglial cells. C-Apochromat 40x/1.2 and C-Apochromat 63x/1.2 water immersion objectives were used to obtain detailed images of glial cell morphology.
Data evaluation and statistical analysis
All data are expressed as mean ± SEM, obtained in n animals. One and two-way repeated measures ANOVA, and subsequent pairwise multiple comparison procedures were applied to compare variables in more than two groups. The two-tailed Student's t test was used to test for statistically significant differences between two experimental groups. Values for P < 0.05 were considered significant.
Results
P2X7 reduces rapid development of brain edema after ischemic infarction
We evaluated the progression of neurological deficits, infarct size and brain swelling during 72 h after tMCAO. Mice lacking P2X7 tended to initially (6 h) experience more severe neurological problems than those of the WT (P = 0.169), but these findings only constitute a non-significant trend that leveled out until the end of the observation (Fig. 1a) . Furthermore, the postischemic interval was characterized by a significantly greater midline shift in the P2X7-deficient group at 24 h after reperfusion (P = 0.026), (Fig. 1c) . Whereas the WT group expressed a significant enlargement of the midline shift over time (P = 0.046), the midline was not further shifted in the P2X7-deficient animals until 72 h after surgery. Of note, the values represented in Fig. 1c correspond to the overall swelling of the infarcted hemisphere. In order to calculate these values, we determined the line separating both hemispheres, and for this task, we used high resolution RARE images and T2 maps (also see Online Resource 1). Due to resolution, these two types of images were superior to DWI images regarding the recognizability of anatomical structures marking the midline. Since only the position of these anatomical landmarks (and the total brain volume as restricted by the intact mouse skull) affected the results depicted in Fig. 1c , it is not possible to deduct the respective share of cytotoxic and vasogenic brain edema from these measurements.
Because the infarct size appeared to be slightly larger in P2X7-deficient mice (Fig. 1b) , one could speculate the corresponding pronounced midline shift to be a mere result of an increased volume of infarcted tissue. We therefore established the ratio between swelling of the infarcted hemisphere and the respective lesion volume and obtained strongly increased values for P2X7-deficient animals at 24 h that confirm our aforementioned results (P = 0.011, Fig. 1d) . Consistent with the neurological scores after 72 h, differences regarding brain edema were no longer detectable. At this time point in addition to the midline shift, the relative brain swelling of WT mice had significantly increased (P = 0.032).
Although T2 relaxation times and ADC did not differ at any time between WT and P2X7 −/− mice, both displayed significantly prolonged T2 relaxation times and decreased ADC when compared with sham-operated animals ( Fig. 2 ; Table 1 , upper panel), indicating the development of a cytotoxic edema, i.e., the shift of extracellular water to intracellular compartments [19] . Furthermore, T2 relaxation times significantly grew between 24 and 72 h after MCAO (WT: P = 0.009; P2X7
−/−
: P = 0.005), indicating interstitial water accumulation in all animals that underwent tMCAO (Table 1, upper panel) .
Sham-operated animals did not show neurological deficits. T2 relaxation times as well as ADC values of the ipsi-or contralateral brain hemispheres in sham-operated mice did not differ from those obtained in the contralateral hemisphere of animals that underwent tMCAO. Hence, contralateral values served as a reference for unaffected tissue in Table 1 .
Microglia activation is attenuated in animals lacking P2X7
The ionized calcium binding adaptor protein 1 (Iba1), a marker expressed in microglia and macrophages that is upregulated after tissue damage, was used to evaluate microglial activation 72 h after tMCAO [20] . Activated astrocytes were monitored by expression of glial fibrillary acidic protein (GFAP). Both Iba1 and GFAP expression were highly increased after cerebral ischemia in animals that underwent tMCAO when compared with sham-operated mice and represent the characteristic spatial pattern of glia cells with respect to the infarct site (Fig. 3, left panel) . In order to obtain information regarding the distribution of activated glial cells, we defined a cortical ROI that encompasses the penumbra and adjacent brain tissue (Fig. 4a, b, Fig. 5a, b) and measured immunofluorescence intensity along this ROI. Since cellular integrity was almost completely lost in the infarct cores, immunofluorescence signals in these regions were inconsistent and considered non-specific. Consistent with microglial activation, immunofluorescence of Iba1 was highly enhanced at the infarct border in both WT and P2X7
−/− mice, where microglia literally formed a wall between the infarct core and the peri-infarct area (Fig. 4c ). This microglial response was significantly attenuated in the absence of P2X7 (P = 0.016, Fig. 4d) . Notably, this effect was not caused by a decreased microglial cell number but reflected a lower per-cell Iba1 immunoreactivity in P2X7 −/− mice compared with their WT (302.4 ± 15.7 vs. 300.0 ± 7.8 microglial cells per ROI in WT Fig. 1 (Fig. 3 , magnified images of Iba1 and GFAP). Reactive astrocytes were seen in a broader region outside the infarct core (Fig. 5c ). Although both activation of microglia and (Fig. 5d) .
Laminin, an extracellular matrix component primarily located in the basement membranes of vascular endothelial cells, is a well-established marker for cerebral blood vessels which is known to be upregulated following brain ischemia [22, 23] . Since P2X7 may influence tissue remodeling and angiogenesis [24, 25] , we examined whether genetic deletion of the receptor affects the expression level of laminin. While laminin immunoreactivity in the peri-infarct tissue of WT and P2X7 −/− mice and in sham-operated animals was very low, intense immunofluorescence could be measured in determined ROIs within the infarct core (Online Resource 2). However, no difference in laminin-immunofluorescence intensity could be detected between the two groups that underwent tMCAO (Online Resource 3).
P2X7 does not protect from severe neurological deterioration after pMCAO
We had initially chosen to permanently occlude the middle cerebral artery to model human stroke, where recanalization can often not be achieved [26] . While some previous studies reported high survival rates for days after pMCAO (e.g., [27] ), others pointed out that the high mortality poses a major challenge [28] . In our study, 1/6 WT and 2/7 P2X7 −/− mice had to be euthanized during the first hours after pMCAO. Due to severe neurological deterioration and in the interest of animal welfare, we decided to euthanize the remaining animals 24 h after surgery. We did not detect any relation between the presence of a functional P2X7 receptor and progression of neurological deficits or the resulting need for euthanasia. Significant differences could neither be observed regarding infarct volumes, T2 relaxation times, and ADC of WT and P2X7
−/− groups ( Table 1 , lower panel). However, these findings have to be interpreted keeping the limited group size in mind.
Discussion
The aim of the present work was to characterize the role of P2X7 in pathophysiological events following ischemic stroke for a prolonged period of time. We found P2X7 −/− mice to rapidly develop a significantly larger brain edema, a condition accompanied by a tendency towards more severe neurological deficits whereby the latter did, however, not reach significance. Microglial activation 72 h after the initial insult was significantly attenuated in animals lacking P2X7. No differences were observed in neurological scores and infarct size in the initially chosen permanent MCAO model. We did not pursue this approach any further due to serious neurological deficits and lethality. Due to the high mortality after pMCAO, we are unable to draw reliable conclusions regarding the role of P2X7 after permanent cerebral ischemia. The change to transient MCAO was associated with a reduction of infarct size and neurological scores, which displayed a trend towards a better outcome when P2X7 is functionally active. Furthermore, we found that animals deficient for P2X7 were more prone to develop severe brain edema within the first 24 h after onset of transient ischemia. During this early phase of ischemic stroke, cytotoxic brain edema reaches its maximum [29] and is clinically followed by a midline shift that is used as a criterion for the development of brain edema in stroke patients [30] . The mechanisms causing brain edema are only partly understood. As a result of the ischemia, energy depletion in the irrigation area causes the failure of ion pumps and, thus, provokes the intracellular accumulation of excess fluid. Only at later stages of the disease, blood-brain barrier breakdown induces the additional formation of vasogenic brain edema. In contrast, brain pathologies involving direct impairment of the blood-brain barrier primarily entail the formation of vasogenic brain edema. In contrast to our study, genetic deletion of P2X7 has been shown to limit edemic development in a model of traumatic brain injury. Differences regarding the pathogenesis of edema formation may account for this apparent contradiction [7] . Indeed, in agreement with our data, P2X7 receptor agonists have been reported to improve behavioral dysfunctions in the MCAO model of ischemic stroke 24 h after surgery [12] . The transition from a mainly cytotoxic to a more vasogenic edema between day 1 and day 3 after surgery may also explain why differences between WT and P2X7 −/− mice leveled out.
Furthermore, a recent study showed that glial cell recruitment takes place early after onset of ischemia and that concentrations of interleukins IL-1β, IL-6, and TNF-α peak 24 h after tMCAO [31] . Since P2X7 is known to affect the expression of all these cytokines, these findings may hint at a greater receptor activity at this time point and thus explain why we detected significant differences only during the early phase of brain ischemia. Both WT and P2X7 −/− mice showed increased immunofluorescence signals pointing to microglial and astroglial activation 72 h after tMCAO. The microglial response, however, was significantly attenuated in P2X7-deficient animals. We selected this survival time to evaluate glial responses because previous studies described a peak of glial activation within a few days after MCAO [32] . In future studies, the histological shown are based on measurements from left to right along the complete ROI and were normalized to immunofluorescence intensities measured in contralateral reference region. Grey traces represent the WT, and black traces represent P2X7 −/− mice. Continuous traces describe GFAP immunofluorescence after tMCAO, and dotted traces derive from shamoperated animals. d GFAP activation in peri-infarct tissue depicted as ratio of GFAP immunofluorescence between infarcted hemisphere and contralateral reference region. n = 9 for tMCAO groups, n = 4 for sham groups and functional state of either cell type at earlier times after cerebral ischemia may reveal the mechanisms which cause aggravated brain edema in P2X7 −/− mice.
Although the non-opioid metamizol may be responsible for weak anti-inflammatory effects and attenuation of glial activation, all animals received the same dose of analgesic, and such effects should therefore affect both WT and P2X7 −/− mice equally. Possible explanations for our observations have to consider that P2X7 is expressed in microglia as well as in astrocytes and both cell types may exert damaging or favorable effects, depending on their activation state and the actual point of time after ischemia/reperfusion. Microglia are known to be able to differentiate into distinct phenotypes. Although ischemic brain damage initially facilitates transition towards the pro-inflammatory M1 type, microglial cells retain their ability to shift between one and the other. The presence of M2 microglia favors tissue repair and studies involving mice lacking IL-4, which evokes transition towards the M2 phenotype, have shown that the outcome worsens in absence of M2 microglia [33] . In a recent study, it has been shown that IL-4 expression is enhanced in the penumbra of infarcted tissue, where it reaches its peak during the first 24 h [34] . Even though data regarding microglia is not available, it has been proven that M2 macrophages do express P2X7 [35] . It is thus tempting to speculate that the protective M2 phenotype may critically rely on an intact P2X7. Consequently, a lacking functional P2X7 receptor in M2 microglial cells may cause the detrimental effects observed 24 h after MCAO in the absence of a functional P2X7 receptor, as has been proposed before [36] . On the other hand, there is extensive evidence that antagonism of P2X7 exerts neuroprotective effects, presumably by preventing intracellular Ca 2+ overloads. Thus, sustained activation of P2X7 has been shown to facilitate glutamate release and cause neuronal and glial cell death [37] . P2X7 activation may also lead to detrimental, prolonged neuroinflammation [37] . The fact that P2X7 antagonism confers beneficial effects by preventing microglial cell death as well as neuroinflammation once more illustrates the dual role played by microglia in pathophysiological events following brain ischemia.
Aquaporin 4 (AQP4) is a water permeable channel mainly expressed in astrocytic processes adjacent to cerebral capillaries and plays an important role in bidirectional water transport [38] . The cytotoxic brain edema prevailing in acute cerebral ischemia can be reduced by downregulation of AQP4. Since AQP4 downregulation has been reported to be triggered upon P2X7 activation [39] , this mechanism could serve as an explication for the exacerbated brain edema developed in P2X7-deficient mice in this study. In cases of vasogenic brain edema, however, AQP4-mediated water movement is crucial for fluid clearance, and AQP4 downregulation by P2X7 would be detrimental [38] . It is also conceivable that P2X7-dependent mechanisms occur downstream of GFAP-related astroglial activation, as has been shown in a recent study comparing WT and P2X7 −/− mice subjected to cerebral ischemia. In case of preconditioning to ischemic insults, astrocytic P2X7 was shown to mediate ischemic tolerance and to provide neuroprotection even though no differences between the two genetic phenotypes were found in GFAP immunofluorescence [40] . Similar to our results, infarct sizes analyzed by post mortem 2,3,5, triphenyltetrazolium chloride (TTC) staining were not different between the genotypes in this study.
In our study, laminin immunofluorescence was very low in intact brain tissue. This observation is consistent with the results of earlier studies that have also described a considerable increase in signal intensity at sites of cerebral lesions [41] . It has been reported that this phenomenon is provoked by the breakdown of the neurovascular unit, which leaves the corresponding epitopes accessible for the antibodies, a development that is reversed upon the re-establishment of gliovascular junctions [42] . Our results indicate that this process is not strongly influenced by P2X7.
Conclusions
The development of brain edema is a life-threatening complication of cerebral ischemia, the resulting increase in intracranial pressure further compromises adjacent brain structures and exacerbates the disease. Effective therapeutic measures are necessary to improve the functional outcome for the patient. Here, we identified a beneficial role of P2X7 activation in acute ischemic stroke. Our results emphasize the need for a detailed understanding of the receptor's role in neuroinflammation dependent on the underlying disease, the target cell type, and the time passed since the onset of ischemia in order to decide on a possible therapeutic P2X7 modulation after ischemic stroke.
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